Biodexa Announces Major Milestone For Its Serenta Registrational Phase 3 Trial In Fap
BDRX•Serenta registrational phase 3 trial milestone
Biodexa Pharmaceuticals PLC 5MP2y.F:
- Biodexa announces major milestone for its Serenta registrational phase 3 trial in FAP
Source text: ID:nGNX3tz7y
Further company coverage: [5MP2y.F]
Related News
Bio-Techne declares Q3 2026 distribution of R$ 0.01 per unit, payable Sept. 10
TECH•
eBay report flags “Used in Japan” as global quality marker for resale market
EBAY•
